Our Pipeline

Our unique IND engine has helped us identify novel pathways and targets in immuno-oncology and other areas.

Five Prime Programs

Bemarituzumab

FGFR2b antibody
FIGHT trial (with chemo) in 1L gastric/GEJ cancer

FPA150

B7-H4 antibody
Breast, ovarian and endometrial cancers

FPT155

CD80-Fc Fusion
Multiple tumor settings
Multiple tumor settings

Partnered Programs

Cabiralizumab

CSF-1R antibody
Cabira + OPDIVO® in 2L pancreatic cancer
Cabira + OPDIVO in 1L pancreatic maintenance
Cabira + OPDIVO in resectable biliary tract cancer
Cabira + anti-CD40 + OPDIVO in melanoma, NSCLC and RCC

BMS-986258

TIM-3 antibody
Multiple tumor settings
Multiple tumor settings